Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Faculty Opinions recommendation of A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients. — Giuseppe Remuzzi | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Faculty Opinions recommendation of A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients.
Shared by
Giuseppe Remuzzi
Faculty Opinions recommendation of A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients.
Dataset
en
Authors
Giuseppe Remuzzi
FC
Federica Casiraghi
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Dataset
Faculty Opinions recommendation of Outcomes of kidney transplantation in HIV-infected recipients.
Giuseppe Remuzzi
,
Arrigo Schieppati
Dataset
Faculty Opinions recommendation of Volume progression in polycystic kidney disease.
Giuseppe Remuzzi
Dataset
Faculty Opinions recommendation of Drug-Induced Acute Kidney Injury.
Giuseppe Remuzzi
,
Camillo Carrara
Dataset
Faculty Opinions recommendation of A neutrophil response linked to tumor control in immunotherapy.
Giuseppe Remuzzi
,
Luca Perico
Dataset
Faculty Opinions recommendation of Sirolimus and kidney growth in autosomal dominant polycystic kidney disease.
Giuseppe Remuzzi
,
Arrigo Schieppati
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.